Publications by authors named "M C Merlano"

Claim this Profile
P
Predicting the response to immunotherapy from gene expression data in HER2-negative breast cancer.
Caterina A M La Porta, Ornella Garrone, Marco Merlano, Stefano Zapperi

Commun Med (Lond)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimodality immunotherapy with avelumab, short-course radiotherapy, and cyclophosphamide in head and neck cancer: the CONFRONT phase I-II trial.
M C Merlano, N Denaro, M Paccagnella, A Abbona, D Galizia

ESMO Open· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Evidence in the Systemic Treatment of Brain Metastases from Breast Cancer and Future Perspectives on New Drugs, Combinations and Administration Routes: A Narrative Review.
Ornella Garrone, Fiorella Ruatta, Carmen Giusy Rea, Nerina Denaro, Michele Ghidini, Marco C Merlano

Cancers (Basel)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Moderate physical activity during neoadjuvant chemotherapy in breast cancer patients: effect on cancer-related inflammation and pathological complete response-the Neo-Runner study": [ESMO Open 9 (2024) 10.1016/j.esmoop.2024.103665].
O Garrone, M Paccagnella, A Abbona, F Ruatta, P Vanella, M C Merlano

ESMO Open· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SMS-Based Active Surveillance of Adverse Events following Immunization in Children: The VigiVax Study.
Laura Augusta Gonella, Francesca Moretti, Annalisa Capuano, Caterina De Sarro, Lorenza Ferrara, Maria Caterina Merlano

Vaccines (Basel)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis